Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Other financing activities (2016 - 2023)

Historic Other financing activities for Jaguar Health (JAGX) over the last 6 years, with Q4 2023 value amounting to $6000.0.

  • Jaguar Health's Other financing activities changed N/A to $6000.0 in Q4 2023 from the same period last year, while for Jun 2024 it was -$14000.0, marking a year-over-year increase of 9720.56%. This contributed to the annual value of $1.2 million for FY2023, which is N/A changed from last year.
  • Latest data reveals that Jaguar Health reported Other financing activities of $6000.0 as of Q4 2023.
  • Jaguar Health's Other financing activities' 5-year high stood at $1.6 million during Q3 2019, with a 5-year trough of -$1.6 million in Q4 2019.
  • Its 3-year average for Other financing activities is $159571.4, with a median of $6000.0 in 2023.
  • The largest annual percentage gain for Jaguar Health's Other financing activities in the last 5 years was 79213.48% (2023), contrasted with its biggest fall of 79213.48% (2023).
  • Jaguar Health's Other financing activities (Quarter) stood at -$1.6 million in 2019, then soared by 88.66% to -$178000.0 in 2022, then skyrocketed by 103.37% to $6000.0 in 2023.
  • Its last three reported values are $6000.0 in Q4 2023, -$20000.0 for Q3 2023, and $15000.0 during Q2 2023.